ORLANDO, Fla. — Using fixed-ratio insulin combinations (FRC) can reduce side effects such as nausea in treating diabetes, an advantage that should persuade clinicians to consider these drugs more ...

We conducted a 78-week randomized, open-label, treat-to-target phase 3a trial (including a 52-week main phase and a 26-week extension phase, plus a 5-week follow-up period) involving adults with type ...